| HOME >> BIOLOGY >> TECHNOLOGY |
Table 55: Immuno Chemistry, India, Company Share by Revenue ($m), USD Actual 2009-2010 124
Table 56: Infectious Immunology Market, India, Segment Contribution (%), 2010 127
Table 57: Infectious Immunology, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 129
Table 58: Infectious Immunology, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 131
Table 59: Infectious Immunology, India, Distribution Share by Revenue ($m), USD Actual, 2009-2010 132
Table 60: Infectious Immunology, India, Company Share by Revenue ($m), USD Actual 2009-2010 134
Table 61: Microbiology Culture Market, India, Segment Contribution (%), 2010 137
Table 62: Microbiology Culture, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 139
Table 63: Microbiology Culture, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 141
Table 64: Microbiology Analyzers, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 143
Table 65: Microbiology Analyzers, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 145
Table 66: Microbiology Culture, India, Distribution Share by Revenue ($m), USD Actual, 2009-2010 146
Table 67: Microbiology Culture, India, Company Share by Revenue ($m), USD Actual 2009-2010 148
Table 68: Clinical Chemisty Market Pipeline Products 162
Table 69: Immuno Chemistry Market Pipeline Products 164
Table 70: Haematology Market Pipeline Products 167
Table 71: Infectious Immunology Market Pipeline Products 169
Table 72: Microbiology Culture Market Pipeline Products 173
Table 73: Histology and Cytology Market Pipeline Products 174
Table 74: Genetic Testing Market Pipeline Products 175
Table 75: Enigma Diagnostics Enters Into Co-Development Agreement With GlaxoSmithKline 179
Table 76: Radient
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |